BARTELS CYTOMEGALOVIRUS IGG EIA— 510(k) K922582
Substantially EquivalentBaxter Diagnostics, Inc.
FDA 510(k) clearance K922582 for BARTELS CYTOMEGALOVIRUS IGG EIA, Substantially Equivalent on 1993-04-08. Applicant: Baxter Diagnostics, Inc.. Device class: 2.
Clearance details
- Applicant
- Baxter Diagnostics, Inc.
- Product code
- Code LFZ
- Device class
- Class 2
- Regulation
- 21 CFR 866.3175
- Advisory panel
- Microbiology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Bellevue, WA, US
Recent devices under product code LFZ
view allMore clearances from Baxter Diagnostics, Inc.
view allData sourced from openFDA. This site is unofficial and independent of the FDA.